Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Upcoming Scientific Meetings in October

Published: Oct 11, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its Lymphoseek studies in breast cancer and melanoma are being presented during the month of October at the American Association of Pharmaceutical Scientists meeting in Chicago, IL, the European Association of Nuclear Medicine conference in Milan, Italy and the American Society for Radiation Oncology meeting in Boston, MA. Details of the presentations and posters are listed below.

Back to news